(435) 292-5548
 Medicare News
Home  ›  Prescription Assistance  ›  Anoro Ellipta

COPD & Asthma

Anoro Ellipta Assistance Programs & Grants

Assistance information last verified: August 2026

AltaMedicare is an independent Medicare agency in Alpine, Utah, founded by Bret Swope, a licensed Medicare agent. We provide educational, no-pressure help comparing Medicare Advantage, Medigap (Medicare Supplement), and Part D at no cost, serving the entire state of Utah. Call or text (435) 292-5548.

Manufacturer programs, charitable grants and Medicare routes for Anoro Ellipta (umeclidinium / vilanterol) — each checked on its official source.

Can I get help paying for Anoro Ellipta?

Yes — GSK's patient assistance program covers Anoro Ellipta and has a Medicare route, but it requires that you have already paid $600 for prescriptions this calendar year. The COPD charitable funds that list Anoro were all closed. Two official cash prices exist for comparison, and an authorized generic is on the market.

  • GSK Patient Assistance Program: Anoro Ellipta is on the published list of eligible products. Medicare route requires a Medicare drug plan, income at or below $47,880 for one person, and $600 already spent on prescriptions this calendar year.
  • GSK Direct to You: $222.94 cash, plus a processing and shipping fee of up to $25 — but only if you are not using insurance. The federal TrumpRx site lists the same inhaler at $247.94.
  • Authorized generic: DailyMed labels "Umeclidinium and Vilanterol Ellipta", and TotalAssist lists the generic on the same fund as the brand.
  • Medicare negotiation: Anoro Ellipta is a SELECTED drug for initial price applicability year 2028. No negotiated price has been published yet.
  • Charitable grants: TotalAssist's COPD fund and COPD health equity fund both list Anoro and both were closed ($1,200 guaranteed / $3,500 maximum). HealthWell's COPD – Medicare Access fund was closed. Good Days has no COPD fund. Anoro is deliberately absent from the asthma funds, because its label is COPD-only.

3 of the 6 programs we checked for Anoro Ellipta were accepting applications when verified in August 2026.

About Anoro Ellipta (umeclidinium / vilanterol)

Anoro Ellipta is a once-daily maintenance inhaler for COPD that combines two different long-acting bronchodilators and no steroid. That combination is what separates it from Breo Ellipta and Trelegy Ellipta, which contain an inhaled steroid — and it is why Anoro is licensed for COPD only and appears on the COPD charitable funds rather than the asthma ones.

Approved uses

  • Maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, to improve airflow

Manufacturer: GSK (GlaxoSmithKline)

Why Anoro Ellipta can be expensive on Medicare

Anoro Ellipta is a once-daily brand inhaler that Part D plans generally place on a brand tier, and COPD maintenance treatment continues indefinitely, so the cost-sharing repeats every month for years. What is unusual here is that there are two published cash prices to compare against your plan: GSK sells Anoro direct for $222.94 plus a fee of up to $25, and the federal TrumpRx site lists it at $247.94, which is the same price with that fee folded in. An authorized generic also exists.

Medicare coverage context

Anoro Ellipta is an inhaler you use yourself, so Medicare covers it under Part D or a Medicare Advantage drug plan. It is one of the 15 drugs CMS selected for the THIRD cycle of Medicare drug price negotiation, with any negotiated price taking effect from January 1, 2028. Selection is not the same as a price: CMS's published file carries no maximum fair price for Anoro Ellipta yet, because the negotiation itself happens first, so no dollar figure is quoted on this page. Part D out-of-pocket costs are capped at $2,100 in 2026, Extra Help lowers cost-sharing for people with limited income and resources, and the Medicare Prescription Payment Plan can spread what you owe across the year.

Check typical Part D coverage · Estimate your drug costs · Compare Part D drug plans

Anoro Ellipta assistance options at a glance

Every program we checked, what kind of help it is, whether people with Medicare can use it, and its status when we verified it. A medication being listed by a program is not the same as the program accepting applications.

About the income limits below: Income limits can differ between assistance programs even when both describe their eligibility as the same percentage of the federal poverty level. The dollar limits shown here come from each program's own published income table, and each program decides which year's poverty guidelines that table is built from and when it takes effect. Treat the figures as belonging to the program they are listed under — they are not interchangeable, and only the program can tell you which table it is applying to your application today.

Anoro Ellipta assistance programs compared
ProgramType of helpPeople with MedicareStatus (August 2026)
GSK Patient Assistance Program Manufacturer patient assistance with conditions Accepting applications
GSK Direct to You (cash price) Manufacturer self-pay pricing with conditions Accepting applications
Anoro Ellipta dollars-off coupon Commercial copay / savings card not eligible Open with limits
TotalAssist — COPD funds Charitable grant may apply Closed to new applicants
HealthWell Foundation — COPD – Medicare Access fund Charitable grant may apply Closed to new applicants
Good Days — no applicable fund Charitable grant not stated No program found
Medicare Extra Help (Part D Low-Income Subsidy) Government program may apply Accepting applications

Manufacturer programs from GSK (GlaxoSmithKline)

A patient assistance program (free or low-cost drug by income) is not the same as a copay card (a commercial discount that usually excludes Medicare). Both are listed so you can see which one applies to you.

Manufacturer patient assistance

GSK Patient Assistance Program

GSK Patient Access Programs Foundation (an independent 501(c)(3) charitable foundation)

Accepting applications Medicare: with conditions

Status: Accepting applications on August 26, 2026. Anoro Ellipta appears on the program's published "List of eligible products".

The GSK Patient Access Programs Foundation supplies certain GSK medicines at no cost to people who meet its income and insurance rules. Anoro Ellipta is one of them. This is free medicine, not a discount.

If you have Medicare: Medicare beneficiaries may apply through GSK's Medicare route for "general" category medicines, which is where Anoro Ellipta sits. The condition to plan around is the spending threshold: you must "have paid a total of $600 for prescriptions in the current calendar year". A Medicare prescription drug plan is required, and income must be at or below the program's table. GSK applies a different rule to its specialty medicines — Nucala has no $600 threshold but excludes Extra Help enrollees — so do not assume the Anoro rule from a Nucala conversation or the reverse.

What it can cover: Anoro Ellipta at no cost to approved patients, supplied through the program.

Who may qualify

  • Live in the United States or Puerto Rico
  • Have a Medicare prescription drug plan and meet the program's other requirements
  • Have paid a total of $600 for prescriptions in the current calendar year
  • Maximum annual gross income (48 states and DC): $47,880 for one person, $64,920 for two, $81,960 for three, $99,000 for four, adding $17,040 for each additional person
  • Higher limits apply in Alaska ($59,850 for one person) and Hawaii ($55,080); Puerto Rico limits are lower ($28,800)
  • Not eligible for Puerto Rico's Government Health Plan Mi Salud, or have applied and been denied

What the application asks for

  • Proof of household income
  • Your Medicare prescription drug plan details
  • Records of prescription spending this calendar year, for the $600 threshold
  • Your prescriber's details — GSK enrollment forms are signed by both patient and provider

How to apply

Start at the GSK Patient Assistance Program page and follow the Medicare route for prescription medicines. Both you and your prescriber sign the enrollment form. Call 1-866-728-4368 with questions or to have a form mailed.

GSK Patient Assistance — Medicare eligibility → 1-866-728-4368

Manufacturer self-pay pricing

GSK Direct to You (cash price)

GSK, dispensed by Alto Pharmacy

Accepting applications Medicare: with conditions

Status: Available on August 26, 2026 with Anoro Ellipta priced at $222.94, plus "a processing and shipping fee of up to $25" per order.

A published cash price for Anoro Ellipta delivered to your home. Useful mainly as a benchmark: it tells you what the inhaler costs without insurance, which is the number to hold your Part D cost-sharing up against.

If you have Medicare: GSK's terms say plainly: "This Offer is not available to patients who wish to use insurance." A Medicare beneficiary is not barred from buying this way, but doing so means paying cash outside your Part D benefit — which also means the spending does not count toward your plan's deductible or the annual out-of-pocket cap. That trade-off only makes sense if the cash price beats what your plan charges you, so compare before you switch. GSK itself adds: "If you have insurance, check with your pharmacy, your price may be lower."

What it can cover: The medication itself at the published price, shipped to you. Not insurance and not a copay reduction.

Who may qualify

  • Not using prescription insurance for this fill
  • A valid prescription sent by your healthcare provider

How to apply

Your provider sends the prescription to the program pharmacy; Alto Pharmacy then confirms receipt and guides you through the next steps. Call Alto on (800) 874-5881.

GSK Direct to You prices → (800) 874-5881

Commercial copay / savings card

Anoro Ellipta dollars-off coupon

GSK

Open with limits Medicare: not eligible

Status: Listed on GSK's coupons page on August 26, 2026. GSK publishes no dollar value — the amount appears only through the site's coupon finder — so no figure is reproduced here. GSK states it is "not currently offering any free trial offers".

A commercial discount for people with private or employer prescription insurance. Not a route for anyone with Medicare.

If you have Medicare: GSK's terms: the coupon "may not be used by government beneficiaries, including but not limited to those enrolled in Medicare or Medicaid." Anoro also has no GSK copay program — that list runs to seven specialty and oncology medicines and does not include any of the Ellipta inhalers.

Who may qualify

  • Commercial (private or employer-sponsored) prescription insurance
  • Not enrolled in Medicare, Medicaid or another government prescription program

How to apply

Commercially insured patients can use the coupon finder on GSK's coupons page. Medicare beneficiaries should apply to the GSK Patient Assistance Program or compare the cash price instead.

GSK coupons and offers →

Charitable grants for Anoro Ellipta

The charitable picture for Anoro Ellipta is narrower than for the steroid-containing inhalers, and the reason is the label rather than the price. Because Anoro is licensed for COPD only, it appears on TotalAssist's COPD fund and COPD health equity fund but not on the asthma funds — where Breo Ellipta, which contains a steroid, does appear. Both COPD funds were closed on August 26, 2026, each paying $1,200 guaranteed up to $3,500. HealthWell's COPD – Medicare Access fund was closed too, and Good Days runs no COPD fund at all. Usefully, TotalAssist lists the generic "Umeclidinium-Vilanterol" on the same fund as the brand, so switching to the authorized generic would not cost you eligibility if a fund reopens. Set alerts on both foundations, and in the meantime work the GSK program, the generic and the cash-price comparison.

Charitable grant

TotalAssist — COPD funds

Patient Advocate Foundation · Chronic obstructive pulmonary disease (COPD) · COPD health equity

Closed to new applicants Medicare: may apply

Status: Both COPD funds were closed to new applicants on August 26, 2026, each with a $1,200 guaranteed and $3,500 maximum award. TotalAssist has no waitlist, so the notification sign-up is what gets you in.

Both "Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr)" and the generic "Umeclidinium-Vilanterol" are named on the COPD approved-medication list, so a switch to the authorized generic would not cost you fund eligibility. Anoro is deliberately absent from TotalAssist's Asthma fund, which matches its COPD-only label.

If you have Medicare: These funds require government-insured coverage — Medicare, Medicaid or TRICARE — that covers your qualifying expenses. Medicare beneficiaries are eligible when a fund is open.

What it can cover: When open: $1,200 guaranteed award and up to $3,500 maximum for medication copays, coinsurance, deductibles and health-insurance premiums. One grant per condition.

Who may qualify

  • Confirmed COPD diagnosis, in treatment, starting within 60 days, or treated in the past 6 months
  • Government-insured coverage (Medicare, Medicaid or TRICARE) that covers your qualifying expenses
  • Household income at or below 500% of the federal poverty level, adjusted for your regional cost-of-living index
  • Confirmed diagnosis matching the fund, and in treatment (or starting within 60 days, or treated in the past 6 months)
  • Legal U.S. resident receiving treatment in the U.S. or a U.S. territory
  • The health-equity fund additionally requires a home zip code in a designated social-vulnerability county

What the application asks for

  • Contact information and Social Security number (or alien number)
  • Annual household income (for pre-screening; proof of income due within 30 days of approval)
  • Health insurance carrier, plan type, policy ID and group number; Medicare supplement or secondary insurance if you have one
  • Copay or coinsurance amounts
  • Your provider's name and contact information, diagnosis (exact date if within 6 months), prescribed medications and treatment plan

How to apply

Sign up for fund notifications (text, email or automated call) at totalassist.org/notify. When a fund opens: You (the patient) apply online — it takes about 15 minutes and you learn immediately whether you are approved — or call 866-512-3861, Monday–Friday 8:30am–5:30pm ET. Patient Advocate Foundation verifies your diagnosis and treatment plan directly with your provider and verifies income automatically; you have 30 days after approval to provide proof of income.

Get notified when a TotalAssist fund opens → 866-512-3861

Charitable grant

HealthWell Foundation — COPD – Medicare Access fund

HealthWell Foundation · Chronic Obstructive Pulmonary Disease – Medicare Access

Closed to new applicants Medicare: may apply

Status: Closed on August 26, 2026. The only open lung fund on HealthWell's published list was Bronchiectasis, which is a different diagnosis.

HealthWell runs a COPD fund designed for Medicare beneficiaries, and it was closed when we checked. HealthWell says replenished funds reopen as quickly as possible and offers real-time alerts.

If you have Medicare: This is a "Medicare Access" fund — built specifically for people with Medicare — which makes it worth an alert even while closed.

What it can cover: When open: copays, coinsurance, deductibles and health-insurance premiums for COPD.

Who may qualify

  • A confirmed COPD diagnosis, verified by your prescriber
  • Some form of health insurance (Medicare qualifies) that covers part of the cost of the drug — discount cards do not count
  • Social Security number (used to prevent duplicate applications)
  • Diagnosis verified by a physician's, nurse practitioner's or physician assistant's signature
  • Treatment in the United States

What the application asks for

  • Some form of health insurance (Medicare qualifies) that covers part of the cost of the drug — discount cards do not count
  • Social Security number (used to prevent duplicate applications)
  • Diagnosis verified by a physician's, nurse practitioner's or physician assistant's signature
  • Treatment in the United States

How to apply

When a fund is open, apply online or by phone; your provider verifies the diagnosis by signature. When a fund is closed, sign up for that fund's real-time alerts — HealthWell says replenished funds reopen "as quickly as possible."

HealthWell disease funds and alerts → (800) 675-8416

Charitable grant

Good Days — no applicable fund

Good Days

No program found Medicare: not stated

Status: Good Days' published disease list on August 26, 2026 contained 57 programs and none of them was COPD.

An honest negative, checked so you do not spend time on a third foundation that has no fund for you.

If you have Medicare: Good Days accepts Medicare beneficiaries for the diseases it covers, but it covers no diagnosis that applies to Anoro Ellipta.

How to apply

Not applicable today. The diseases-covered page shows every fund Good Days runs.

Good Days diseases covered →

How to apply for Anoro Ellipta assistance

  1. Step 1 — Find the applicable assistance program

    Anoro has an unusually wide set of routes for a COPD inhaler — a real manufacturer program, an authorized generic, and two published cash prices. The order that saves the most:

    • Limited income and $600 already spent on prescriptions this year → the GSK Patient Assistance Program.
    • Limited income and resources → Medicare Extra Help through Social Security.
    • Ask your prescriber and plan about the authorized generic, umeclidinium and vilanterol.
    • Compare your plan's cost-sharing against the $222.94 GSK cash price before assuming insurance is cheaper.
    • COPD diagnosis → set alerts on the TotalAssist and HealthWell COPD funds (all closed when checked).

  2. Step 2 — Check whether applications are currently open

    One manufacturer program, three charitable funds, and one cash price that can move.

    • GSK Patient Assistance: the eligible-products list and the Medicare eligibility page are authoritative and both are cited here.
    • TotalAssist: the COPD and COPD health equity fund pages show "Open" or "Closed" and the current award amounts.
    • HealthWell: the disease-funds list shows the COPD – Medicare Access fund and its status.
    • GSK Direct to You: prices are published on the program page and can change without notice.

  3. Step 3 — Check eligibility

    The GSK spending threshold is the gate most people do not expect:

    • GSK Patient Assistance: a Medicare drug plan; income at or below $47,880 for one person or $64,920 for two in the 48 states and DC; and $600 already paid for prescriptions this calendar year.
    • TotalAssist (when open): government insurance covering Anoro; income at or below 500% FPL adjusted for your regional cost-of-living index; a confirmed COPD diagnosis in treatment.
    • HealthWell (when open): insurance that covers part of the drug's cost, a prescriber-verified COPD diagnosis, and treatment in the United States.
    • GSK Direct to You: no income test at all — the only condition is that you are not using insurance for that fill.
    • Extra Help: income below about $23,940 a year for one person or $32,460 for a couple, and countable resources limited to $18,090 or $36,100 in 2026.

  4. Step 4 — Gather your information

    What each route will ask for:

    • Medicare card and your Part D or Medicare Advantage drug-plan card, with policy ID and group number.
    • Your prescription spending so far this calendar year, for GSK's $600 threshold — plan Explanation of Benefits statements or a pharmacy year-to-date printout.
    • Household size and annual gross income, plus proof.
    • Your COPD diagnosis and its date. TotalAssist needs the exact date if it was within the past 6 months.
    • Your prescriber's name, office address and phone.

  5. Step 5 — Complete the application

    Who fills out what:

    • GSK Patient Assistance: both you and your prescriber sign the enrollment form.
    • Extra Help: you (or someone helping you) apply free through Social Security — online, by phone on 1-800-772-1213, or at an office. There is never a fee.
    • TotalAssist (when open): you apply online in about 15 minutes or by phone on 866-512-3861.
    • HealthWell (when open): apply online or by phone; your provider verifies the diagnosis by signature.
    • GSK Direct to You: your provider sends the prescription; Alto Pharmacy contacts you.

  6. Step 6 — Submit and wait for a determination

    What to expect:

    • GSK Patient Assistance: the foundation reviews income and insurance documentation; approved medicine is supplied through the program.
    • Extra Help: Social Security notifies you by mail; your plan then applies the lower copays.
    • TotalAssist (when open): an immediate online decision, with proof of income due within 30 days of approval.
    • GSK Direct to You: no determination — it is a purchase, not an application.

  7. Step 7 — If the program is closed or you don't qualify

    Anoro has more fallbacks than most inhalers on this site:

    • Ask about the authorized generic. DailyMed labels "Umeclidinium and Vilanterol Ellipta", and the TotalAssist COPD fund lists the generic alongside the brand.
    • Compare the $222.94 GSK cash price and the $247.94 TrumpRx price against your plan's cost-sharing. If your plan puts Anoro on a high tier with coinsurance, cash can be the cheaper route — but it will not count toward your out-of-pocket cap.
    • If the $600 threshold is blocking you, remember it is a calendar-year test that resets, and it is easier to meet later in the year.
    • Watch for the Medicare negotiated price. Anoro Ellipta is selected for initial price applicability year 2028; CMS has not published a price yet.
    • Use the Medicare Prescription Payment Plan to spread this year's out-of-pocket costs across monthly payments.
    • Call AltaMedicare — we will work through every route above with you, free.

What you'll need

Only items the programs above actually ask for. Gather these before you start.

  • Medicare card and your Part D or Medicare Advantage drug-plan card — plan name, member ID and group number
  • Prescription details — medication name, strength and dose; prescriber name, office phone and address
  • Diagnosis and date of diagnosis — TotalAssist needs the exact date if diagnosed within the past 6 months
  • Household size and annual household income — and proof — tax return, Social Security or pension statements, or pay stubs
  • Proof of prescription spending this calendar year — GSK's Medicare route requires $600 already paid — plan Explanation of Benefits statements or a pharmacy year-to-date printout
  • Confirmation that the prescription is for COPD — Anoro is not indicated for asthma, and the charitable funds are diagnosis-specific

If assistance is unavailable

A closed fund or a denial is not the end of the road. Check these next:

  1. Ask your prescriber and plan about the authorized generic — DailyMed labels "Umeclidinium and Vilanterol Ellipta" alongside GSK's brand, and TotalAssist covers the generic on the same fund.
  2. Compare two published cash prices against your plan: GSK Direct to You lists Anoro Ellipta at $222.94 plus a fee of up to $25, and the federal TrumpRx site lists it at $247.94. GSK Direct to You
  3. Sign up for TotalAssist fund notifications so you hear the moment a Anoro Ellipta fund reopens — there is no waitlist or queue, so speed matters. TotalAssist notifications
  4. Sign up for HealthWell fund alerts for the same reason; HealthWell says closed funds reopen as funding is replenished. HealthWell disease funds
  5. Check Medicare Extra Help — it does not depend on a fund balance and lowers the cost of every covered drug, not just this one. Medicare Extra Help explained
  6. Ask your doctor's office — many practices have staff who handle assistance applications routinely and can request a formulary exception or a lower-cost alternative.
  7. Use the Medicare Prescription Payment Plan to spread this year's out-of-pocket costs across monthly payments (it does not lower the total). Medicare.gov
  8. Compare Part D and Medicare Advantage drug plans during the fall enrollment period — the tier and cost-sharing for Anoro Ellipta differ from plan to plan. Compare Part D plan options

Could Medicare Extra Help reduce your Anoro Ellipta costs?

Extra Help is not a grant for Anoro Ellipta. It is a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription — so it is worth checking even when a charitable fund is closed, because it does not depend on fund balances.

GSK's Medicare route for Anoro does not exclude Extra Help enrollees — its gate is the $600 prescription-spending threshold, not your subsidy status — so there is nothing to weigh up between the two. Apply for Extra Help on its own merits. With full Extra Help a covered brand-name drug costs about $12.65 in 2026, which for a once-daily maintenance inhaler taken indefinitely is a larger annual difference than it first sounds.

In 2026, people with full Extra Help generally pay no more than $12.65 for a covered brand-name drug. Income must be below about $23,940 a year for one person ($32,460 for a couple) and countable resources under $18,090 ($36,100 for a couple). Apply free through Social Security — online, by phone at 1-800-772-1213, or in person — and never pay anyone to apply for you.

Extra Help explained · Medicare Savings Programs · Estimate your drug costs · Free prescription cost review

Government program

Medicare Extra Help (Part D Low-Income Subsidy)

Medicare / Social Security Administration

Accepting applications Medicare: may apply

Status: Year-round federal program (figures for 2026)

Not a grant for one drug — a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription.

If you have Medicare: For people with Medicare Part D or a Medicare Advantage drug plan who have limited income and resources.

What it can cover: Part D premium and deductible (often to $0) and reduced copays — generally no more than $12.65 for a covered brand-name drug in 2026 with full Extra Help.

Who may qualify

  • Income below 150% of the federal poverty level — about $23,940 a year for one person or $32,460 for a married couple in 2026.
  • Countable resources (savings, investments — not your home or car) limited to $18,090 for an individual or $36,100 for a married couple living together in 2026 (Medicare.gov figures, which include a burial-expense allowance).
  • Automatic if you have Medicaid, Supplemental Security Income (SSI), or a Medicare Savings Program.

What the application asks for

  • Social Security number and Medicare number
  • Income (Social Security, pensions, wages) for you and a spouse you live with
  • Value of savings, investments and other countable resources

How to apply

You (or someone helping you) apply free through Social Security — online, by phone, or at a Social Security office. There is never a fee to apply.

Apply for Extra Help at SSA.gov → 1-800-772-1213

Key terms on this page

Patient assistance program (PAP)
A manufacturer program that provides its medication free or at low cost to people who meet income and insurance rules. Many PAPs accept Medicare Part D enrollees; each sets its own criteria.
Copay card / savings card
A manufacturer discount for commercially insured patients. Federal anti-kickback rules mean these cards generally cannot be used with Medicare, Medicaid or other government insurance.
Charitable copay grant
Money from a nonprofit foundation (for example HealthWell or Patient Advocate Foundation) that pays eligible copays or coinsurance for a specific diagnosis. A drug can be listed while the fund is closed to new applicants.
Federal poverty level (FPL)
A federal income measure that assistance programs use as a yardstick — "300% of FPL", "500% of FPL". The percentage is a rule, but the dollar figure behind it comes from a table each program publishes itself, built on a chosen year of the HHS poverty guidelines. Two programs can quote the same percentage in the same year and still list different dollar limits; compare each program against its own table, not against another program.
Medicare Extra Help
The Part D Low-Income Subsidy: a Medicare program that lowers or eliminates Part D premiums, deductibles and copays for beneficiaries with limited income and resources. You apply through Social Security.
Maximum Fair Price (MFP)
The price Medicare negotiated for a selected drug under the Medicare Drug Price Negotiation Program. It applies to Part D plans, not to the pharmacy cash price, and it lowers what plans and enrollees pay for that drug.

Related medication assistance guides

Incruse Ellipta Assistance & Grants umeclidinium Breo Ellipta Assistance & Grants fluticasone furoate / vilanterol Trelegy Ellipta Assistance & Grants fluticasone furoate / umeclidinium / vilanterol Stiolto Respimat Assistance & Grants tiotropium bromide / olodaterol All prescription assistance Directory & program finder
Common Questions

Anoro Ellipta assistance FAQ

Does Medicare cover Anoro Ellipta?
Yes — Medicare Part D and Medicare Advantage drug plans generally cover Anoro Ellipta, usually on a brand tier. Part D out-of-pocket costs are capped at $2,100 in 2026. If your income and resources are limited, Medicare Extra Help can bring a covered brand-name copay to about $12.65. Anoro is also a selected drug for Medicare price negotiation, with any negotiated price taking effect from January 1, 2028.
Is there an Anoro Ellipta patient assistance program for people on Medicare?
Yes. Anoro Ellipta is on the GSK Patient Assistance Program's published list of eligible products, and the program has a Medicare route. The requirement people miss is the spending threshold: for GSK's "general" medicines, which includes Anoro, you must have "paid a total of $600 for prescriptions in the current calendar year". You also need a Medicare drug plan and income at or below $47,880 for one person in the 48 states and DC. Both you and your prescriber sign the form.
Has Medicare negotiated a price for Anoro Ellipta?
Not yet — but it has been selected. Anoro Ellipta is one of the 15 drugs on CMS's selected-drug list for initial price applicability year 2028. Selection means negotiation happens first and any resulting maximum fair price takes effect January 1, 2028. CMS's published data file carries an empty price column for Anoro today, so anyone quoting you a negotiated Anoro price now is quoting something CMS has not published.
Why is Anoro Ellipta on the COPD charity funds but not the asthma ones?
Because of what its label says. Anoro combines two long-acting bronchodilators — umeclidinium and vilanterol — and contains no inhaled steroid, and the label states it is "NOT indicated for the relief of acute bronchospasm or for the treatment of asthma." The charitable funds follow the approved indication, so Anoro appears on TotalAssist's COPD funds and not its Asthma fund. Breo Ellipta, which contains a steroid and is licensed for both, appears on both. If your inhaler was prescribed for asthma, check that it is the right one for the fund you are applying to.
Should I buy Anoro Ellipta with cash instead of using Medicare?
Sometimes, but check the arithmetic first. GSK sells Anoro direct at $222.94 plus a processing and shipping fee of up to $25, and the federal TrumpRx site lists it at $247.94 — the same price with the fee included. GSK's own terms say the offer "is not available to patients who wish to use insurance", and GSK adds "If you have insurance, check with your pharmacy, your price may be lower." The catch for a Medicare beneficiary is that cash spending outside your Part D benefit does not count toward your deductible or your annual out-of-pocket cap.
Is there a generic for Anoro Ellipta?
Yes, an authorized generic. DailyMed lists five labelled umeclidinium products across two labelers: GSK's Anoro Ellipta, Incruse Ellipta and Trelegy Ellipta, plus "Umeclidinium and Vilanterol Ellipta" and "Umeclidinium Ellipta". TotalAssist lists the generic on the same COPD fund as the brand, so switching would not cost you fund eligibility. Whether it lowers your copay depends on your plan's formulary. See all prescription assistance options.

Sources

Related resources

Assistance information last verified August 2026. Program details — fund status, eligibility, prices, phone numbers — change often; confirm with each program before applying. AltaMedicare does not administer, fund or approve any assistance program. Not medical advice.

Having trouble figuring out your prescription costs?

Bret can help you understand your Medicare prescription coverage and where to look for Anoro Ellipta assistance — free, no pressure. We don't award grants or decide eligibility; the programs above do. We help you find and apply to the right ones.

Text Bret About Anoro Ellipta Call (435) 292-5548